| Target Validation Information | |||||
|---|---|---|---|---|---|
| TTD ID | T55916 | ||||
| Target Name | Voltage-gated potassium channel Kv7.4 (KCNQ4) | ||||
| Type of Target |
Literature-reported |
||||
| Drug Potency against Target | Retigabine | Drug Info | EC50 = 1600 nM | [1] | |
| References | |||||
| REF 1 | Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol. 2000 Sep;58(3):591-600. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.